Clinical Trial Update: Ulipristal Acetate in Symptomatic Uterine Fibroid [Phase 4]

View source ↗

Summary

Phase 4 trial update for ulipristal acetate in symptomatic uterine fibroids has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heavy Menstrual Bleeding
• Uterine Fibroids

Drugs mentioned

• Ulipristal acetate (ulipristal acetate)

Snippet

Sponsor: Mỹ Đức Hospital | Conditions: Uterine Fibroid, Heavy Menstrual Bleeding | Phase 4 | Status: TERMINATED